{"gene":"FHIT","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1997,"finding":"Fhit protein hydrolyzes dinucleotide 5',5'''-P1,P3-triphosphate (ApppA) in vitro; mutation of the central histidine abolishes hydrolase activity. Tumor suppression activity does not require the hydrolase activity, as hydrolase-dead Fhit mutants still suppress tumorigenicity in nude mice.","method":"In vitro enzymatic assay, active-site mutagenesis, nude mouse tumorigenicity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of enzymatic activity with mutagenesis, validated by in vivo functional assay","pmids":["9391102"],"is_preprint":false},{"year":1998,"finding":"Drosophila and C. elegans encode Fhit as a fusion protein with a nitrilase domain (NitFhit); the Drosophila fusion protein retains diadenosine triphosphate (ApppA) hydrolase activity. In mammals, FHIT and NIT1 are encoded by separate genes, suggesting they collaborate in a common biochemical pathway.","method":"Cloning, enzymatic activity assay of fusion protein, expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic assay of ortholog fusion protein with functional evolutionary inference","pmids":["9671749"],"is_preprint":false},{"year":2004,"finding":"Fhit is phosphorylated on tyrosine 114 (Y114) by the Src protein kinase both in vitro and in vivo, identifying Fhit as a physiological Src substrate.","method":"In vitro kinase assay, in vivo phosphorylation studies","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro and in vivo phosphorylation demonstrated with site-specific identification","pmids":["15007172"],"is_preprint":false},{"year":2006,"finding":"Fhit Y114 residue is essential for caspase-dependent apoptosis induction in lung cancer cells; wild-type but not Y114 mutant Fhit inhibits Akt activity and reduces survivin expression, placing Fhit upstream of the PI3K-Akt-survivin pathway.","method":"Adenoviral infection with wild-type and Y114 mutant FHIT, expression profiling, Akt activity assay, apoptosis assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 — site-specific mutagenesis with multiple orthogonal functional readouts (apoptosis, Akt activity, survivin expression)","pmids":["16407838"],"is_preprint":false},{"year":2007,"finding":"Fhit directly binds to the C-terminal domain of β-catenin, recruits to Wnt target gene promoters (cyclin D1, axin2, MMP-14, survivin) as part of the LEF1/TCF/β-catenin complex, and represses transcription of these targets. Enzymatic activity is not required for this function.","method":"Co-IP, ChIP, knockdown experiments, soft-agar assay, enzymatic dead mutant analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding assays, ChIP, and functional mutagenesis with multiple orthogonal methods","pmids":["18077326"],"is_preprint":false},{"year":2006,"finding":"Fhit modulates the mid-S DNA damage checkpoint by regulating expression of checkpoint proteins Hus1 and Chk1; mutation of Fhit Y114 abolishes this checkpoint modulation, and re-expression induces apoptosis in cancer cells but not normal cells.","method":"Exogenous Fhit expression in cells, Western blot for checkpoint proteins, apoptosis assay, Y114 mutant analysis","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — defined pathway placement with mutagenesis, single lab","pmids":["17145874"],"is_preprint":false},{"year":2009,"finding":"Fhit localizes partially to mitochondria and enhances mitochondrial calcium uptake, sensitizing cells to apoptosis. A chimeric fully mitochondrial Fhit retains Ca2+ signaling and proapoptotic properties but loses effects on cell cycle.","method":"Subcellular fractionation, live imaging of Ca2+ signaling in intact and permeabilized cells, chimeric protein expression, apoptosis assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — direct localization experiments with functional consequence established by chimeric protein approach and Ca2+ measurements","pmids":["19622739"],"is_preprint":false},{"year":2008,"finding":"Fhit interacts with Hsp60/Hsp10 chaperone machinery and ferredoxin reductase (Fdxr); substrate-binding and Y114 phosphorylation are required for these interactions and for mitochondrial localization. Loss of these interactions reduces Fhit tumor suppressor activity and impairs oxidative stress-induced apoptosis.","method":"Chemical cross-linking, immunoprecipitation, subcellular fractionation, mutant expression, flow cytometry, ROS measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution of protein complex with mutagenesis and multiple functional readouts","pmids":["19004824"],"is_preprint":false},{"year":2009,"finding":"Fhit binds and stabilizes ferredoxin reductase (Fdxr) in mitochondria; when Fdxr is overexpressed it produces reactive oxygen species (ROS) that induce apoptosis. Fhit-positive cancer cells produce higher ROS upon H2O2 exposure than Fhit-negative cells.","method":"Immunoprecipitation, ROS measurement, apoptosis assay, overexpression experiments","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and functional assay, single lab","pmids":["19486340"],"is_preprint":false},{"year":2012,"finding":"Fhit depletion causes replication stress-induced DNA double-strand breaks and defective replication fork progression (fork stalling and collapse). The mechanism involves regulation of Thymidine kinase 1 (TK1) expression and thymidine triphosphate pool levels; restoring nucleotide balance rescues replication defects and suppresses DNA breakage in Fhit-deficient cells.","method":"DNA combing, DNA damage markers, TK1 expression analysis, thymidine supplementation rescue, Fhit knockout mouse tissue analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including direct replication fork analysis, rescue experiments, and in vivo validation","pmids":["23209436"],"is_preprint":false},{"year":2012,"finding":"Silencing Fhit gene expression in MHC-I-positive tumor cells causes transcriptional down-regulation of antigen-processing machinery (APM) components and MHC-I heavy chains, reducing MHC-I surface expression. Transfection of Fhit into MHC-I-negative tumor cells restores MHC-I surface expression.","method":"siRNA knockdown, FHIT transfection, flow cytometry, RT-PCR","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional gain/loss of function experiments with defined cellular phenotype","pmids":["22451343"],"is_preprint":false},{"year":2014,"finding":"FHIT suppresses EMT and metastasis in lung cancer through upregulation of miR-30c, which directly targets metastasis genes MTDH, HMGA2, VIM, and FN1.","method":"In vivo metastasis assay, in vitro migration/invasion assay, miRNA target validation, gain/loss of function experiments","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro assays with defined molecular targets, single lab","pmids":["25340791"],"is_preprint":false},{"year":2009,"finding":"Nit1 and Fhit tumor suppressor activities are additive in vivo; double Fhit(-/-)Nit1(-/-) knockout mice develop more tumors than Fhit(-/-) mice alone, suggesting they act in distinct pathways in mammals. Both Nit1 and Fhit localize to cytoplasm and mitochondria but not nuclei.","method":"Double knockout mouse tumor susceptibility assay, subcellular fractionation/localization, cell stress assays","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis via double-knockout mouse model with defined phenotypic readout","pmids":["19479888"],"is_preprint":false},{"year":2012,"finding":"Fhit function in suppressing DNA damage requires a functional HIT domain and the Y114 residue, is independent of Atr or Atm kinases, but is dependent on Chk1 kinase activity, suggesting Fhit and Chk1 cooperate to prevent replication stress-induced DNA damage.","method":"Mutant expression studies, kinase inhibitor experiments, DNA damage assays in Fhit-deficient cells","journal":"Advances in biological regulation","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis and epistasis by kinase inhibition, single lab","pmids":["23102829"],"is_preprint":false},{"year":2015,"finding":"Fhit loss-induced DNA damage (via reduced TK1 and replication stress) creates optimal substrates for APOBEC3B-mediated mutagenesis; FHIT-low/APOBEC3B-high lung adenocarcinomas display significantly increased APOBEC signature mutations. Thymidine supplementation (rescuing nucleotide balance) decreases APOBEC-induced TP53 mutations in FHIT-low cells.","method":"TCGA data analysis, in vitro FHIT silencing, TP53 mutation analysis, thymidine rescue experiments","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2-3 — mechanistic link established by rescue experiment in vitro, supported by TCGA data","pmids":["25401976"],"is_preprint":false},{"year":2019,"finding":"FHIT functions as a BMPR2 modifier; reduced FHIT expression is associated with endothelial and smooth muscle cell dysfunction in pulmonary arterial hypertension. Fhit-/- mice develop exaggerated hypoxic pulmonary hypertension. Enzastaurin upregulates FHIT expression and reverses experimental pulmonary hypertension.","method":"siRNA high-throughput screen, Fhit knockout mouse model, pharmacological rescue (enzastaurin), in vitro cell dysfunction assays","journal":"American journal of respiratory and critical care medicine","confidence":"Medium","confidence_rationale":"Tier 2 — knockout mouse phenotype with pharmacological rescue, mechanistic link to BMPR2 pathway defined","pmids":["30107138"],"is_preprint":false},{"year":1997,"finding":"Fhit protein is localized to the cytosolic compartment in renal tubular epithelium, as determined by immunofluorescence and biochemical fractionation.","method":"Immunofluorescence, biochemical subcellular fractionation","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization by two independent methods","pmids":["9403704"],"is_preprint":false},{"year":2001,"finding":"Fhit protein is localized to the nucleus and plasma membrane in rat tissues, as determined by subcellular fractionation of multiple tissues.","method":"Biochemical fractionation, immunoblot analysis of subcellular fractions","journal":"Molecular and cellular biochemistry","confidence":"Low","confidence_rationale":"Tier 3 — single method, single lab; conflicts with other localization data","pmids":["11768238"],"is_preprint":false},{"year":2017,"finding":"Fhit expression impacts translation of hundreds of cancer-associated mRNAs, including changes in 5'-UTR ribosome occupancy; this is consistent with Fhit's enzymatic ability to degrade m7GpppN caps generated during 3'-5' mRNA decay, potentially affecting translational regulation.","method":"Ribosome profiling (ribosome occupancy assay) in Fhit-positive vs. Fhit-negative cells","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide ribosome profiling with mechanistic hypothesis grounded in Fhit enzymatic activity","pmids":["29282095"],"is_preprint":false},{"year":2023,"finding":"Acetylcholine promotes lung adenocarcinoma cell migration and invasion via the α5-nAChR/DNMT1/FHIT axis; α5-nAChR activation increases DNMT1 expression, which methylates and silences FHIT, promoting EMT.","method":"In vivo chronic stress mouse model, in vitro cell migration/invasion assays, DNMT1 overexpression/silencing, FHIT methylation analysis","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro mechanistic pathway defined with multiple components","pmids":["37029227"],"is_preprint":false}],"current_model":"Fhit is a diadenosine polyphosphate hydrolase whose tumor suppressor functions are largely independent of its catalytic activity but require substrate binding and the tyrosine-114 residue; Fhit acts through multiple mechanisms including: direct binding to β-catenin to repress Wnt target gene transcription, partial localization to mitochondria where it interacts with Hsp60/Hsp10 and ferredoxin reductase to modulate ROS-induced apoptosis and intramitochondrial calcium uptake, regulation of Thymidine kinase 1 expression to maintain nucleotide pool balance and prevent replication stress-induced DNA breaks, modulation of the Chk1-dependent DNA damage checkpoint, and upregulation of miR-30c to suppress EMT-related genes; Fhit is also phosphorylated by Src kinase at Y114, and its loss initiates a mutator phenotype through genome instability that facilitates oncogenic progression."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing that FHIT is a diadenosine triphosphate hydrolase whose tumor suppression is catalytically independent resolved the paradox of how a metabolic enzyme could function as a tumor suppressor.","evidence":"In vitro enzymatic assay with active-site mutagenesis; hydrolase-dead mutants still suppressed tumorigenicity in nude mice","pmids":["9391102"],"confidence":"High","gaps":["The substrate-binding vs. catalytic distinction was not yet mapped to specific residues beyond the catalytic histidine","The downstream effector pathway for tumor suppression was unknown"]},{"year":1998,"claim":"Discovery that Drosophila and C. elegans encode FHIT fused with a nitrilase domain (NitFhit) established evolutionary conservation and suggested functional collaboration with NIT1 in mammals.","evidence":"Cloning and enzymatic assay of Drosophila NitFhit fusion protein","pmids":["9671749"],"confidence":"High","gaps":["The shared biochemical pathway between FHIT and NIT1 in mammals was not identified","Whether the fusion architecture reflects obligate functional coupling was unclear"]},{"year":2004,"claim":"Identification of Y114 as a Src phosphorylation site provided the first post-translational regulatory mechanism for FHIT and a critical residue for subsequent functional dissection.","evidence":"In vitro kinase assay and in vivo phosphorylation studies","pmids":["15007172"],"confidence":"High","gaps":["Functional consequence of Y114 phosphorylation on tumor suppression was not yet tested","Whether Src-mediated phosphorylation activates or inhibits FHIT was unresolved"]},{"year":2006,"claim":"Demonstration that Y114 is required for caspase-dependent apoptosis and Akt/survivin pathway inhibition linked Src phosphorylation to a defined tumor-suppressive signaling axis, and that FHIT modulates the Hus1/Chk1 DNA damage checkpoint.","evidence":"Y114 mutant vs. wild-type adenoviral expression in lung cancer cells with apoptosis, Akt activity, and checkpoint protein readouts","pmids":["16407838","17145874"],"confidence":"High","gaps":["Whether Akt inhibition is direct or indirect was not resolved","Relationship between checkpoint modulation and apoptosis induction was unclear"]},{"year":2007,"claim":"Discovery that FHIT directly binds β-catenin and represses Wnt target gene transcription independently of catalytic activity revealed a nuclear transcriptional repressor function distinct from its metabolic role.","evidence":"Co-IP, ChIP at Wnt target promoters, knockdown, enzymatic-dead mutant analysis","pmids":["18077326"],"confidence":"High","gaps":["Mechanism of transcriptional repression (co-repressor recruitment, chromatin remodeling) was not defined","Whether FHIT enters the nucleus or acts at the cytoplasmic level on β-catenin was not fully clarified"]},{"year":2008,"claim":"Identification of Hsp60/Hsp10 and ferredoxin reductase as mitochondrial FHIT-interacting partners, requiring substrate-binding and Y114, established a mitochondrial axis for FHIT's proapoptotic function through ROS generation.","evidence":"Chemical cross-linking, immunoprecipitation, subcellular fractionation, ROS measurement with mutant panel","pmids":["19004824","19486340"],"confidence":"High","gaps":["How FHIT is imported into mitochondria without a canonical transit peptide was unknown","Whether Fdxr stabilization is sufficient for ROS-mediated apoptosis independently of other FHIT functions was unclear"]},{"year":2009,"claim":"Demonstrating that mitochondrial FHIT enhances calcium uptake and sensitizes cells to apoptosis — while a fully mitochondrial chimera loses cell-cycle effects — separated FHIT's mitochondrial proapoptotic function from its cytoplasmic/nuclear roles.","evidence":"Live Ca2+ imaging in intact and permeabilized cells, chimeric mitochondrial-targeted FHIT","pmids":["19622739"],"confidence":"High","gaps":["The calcium channel or transporter modulated by FHIT was not identified","Quantitative contribution of mitochondrial vs. non-mitochondrial FHIT to tumor suppression in vivo was undefined"]},{"year":2009,"claim":"Double-knockout mouse studies showing additive tumor susceptibility of Fhit and Nit1 loss established that these evolutionarily linked genes act through distinct tumor-suppressive pathways in mammals.","evidence":"Fhit−/−Nit1−/− double-knockout mouse tumorigenesis assay with subcellular localization","pmids":["19479888"],"confidence":"Medium","gaps":["The Nit1-specific pathway was not defined","Whether cytoplasmic vs. mitochondrial co-localization mediates any residual functional overlap was not tested"]},{"year":2012,"claim":"Discovery that FHIT loss causes replication fork collapse through TK1 downregulation and nucleotide imbalance provided the first genome-instability mechanism for FHIT tumor suppression, explaining how early FHIT loss drives a mutator phenotype.","evidence":"DNA combing, DNA damage markers, TK1 expression, thymidine supplementation rescue, Fhit-knockout mouse validation","pmids":["23209436"],"confidence":"High","gaps":["How FHIT regulates TK1 transcription was not established","Whether nucleotide imbalance fully accounts for all FHIT-dependent DNA damage was unclear"]},{"year":2012,"claim":"Epistasis experiments placed FHIT's DNA-damage suppression as dependent on Chk1 but independent of ATR/ATM, refining its position in the replication stress response.","evidence":"Kinase inhibitor experiments with FHIT mutants and DNA damage assays","pmids":["23102829"],"confidence":"Medium","gaps":["Direct physical or signaling link between FHIT and Chk1 was not shown","How FHIT bypasses ATR-dependent Chk1 activation was unexplained"]},{"year":2014,"claim":"Identification of miR-30c as a FHIT-induced microRNA that suppresses EMT genes (MTDH, HMGA2, VIM, FN1) extended FHIT's tumor-suppressive reach to metastasis and epithelial-mesenchymal transition control.","evidence":"In vivo metastasis assay, miRNA target validation, gain/loss-of-function in lung cancer cells","pmids":["25340791"],"confidence":"Medium","gaps":["Mechanism by which FHIT upregulates miR-30c was not defined","Whether miR-30c mediates FHIT effects in non-lung tissues was untested"]},{"year":2015,"claim":"Linking FHIT loss-induced replication stress to APOBEC3B mutagenesis explained how early FHIT silencing amplifies the somatic mutation burden driving cancer progression.","evidence":"TCGA analysis of FHIT-low/APOBEC3B-high tumors, in vitro FHIT silencing with thymidine rescue reducing APOBEC-induced TP53 mutations","pmids":["25401976"],"confidence":"Medium","gaps":["Whether APOBEC3B access to ssDNA at stalled forks is the sole mechanism was not proven","In vivo validation in mouse models was lacking"]},{"year":2017,"claim":"Ribosome profiling revealed that FHIT expression reshapes translation of hundreds of cancer-associated mRNAs, consistent with its ability to degrade m7GpppN cap dinucleotides from mRNA decay intermediates.","evidence":"Genome-wide ribosome occupancy profiling in FHIT-positive vs. FHIT-negative cells","pmids":["29282095"],"confidence":"Medium","gaps":["Direct evidence that cap-dinucleotide hydrolysis by FHIT alters specific mRNA translation was not provided","Whether translational changes are primary or secondary to FHIT's other functions was unclear"]},{"year":2019,"claim":"Discovery that FHIT modifies the BMPR2 pulmonary arterial hypertension phenotype, with Fhit−/− mice developing exaggerated hypoxic pulmonary hypertension reversed by enzastaurin, extended FHIT's physiological roles beyond cancer.","evidence":"siRNA screen, Fhit-knockout mouse hypoxia model, pharmacological rescue with enzastaurin","pmids":["30107138"],"confidence":"Medium","gaps":["Molecular mechanism linking FHIT to BMPR2 signaling was not defined","Whether replication stress or other FHIT pathways mediate the vascular phenotype was unknown"]},{"year":null,"claim":"The mechanism by which FHIT regulates TK1 transcription, how it is imported into mitochondria without a canonical transit peptide, and whether its translational regulatory function via cap-dinucleotide hydrolysis is physiologically significant remain open questions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No transcription factor or promoter element identified for FHIT-dependent TK1 regulation","Mitochondrial import mechanism is undefined","Causal link between cap hydrolysis and translational changes is not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,5,9]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[16]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[6,7,12]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,5,15]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3,6,7,8]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[9,13,14]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[9,13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,11,14]}],"complexes":["LEF1/TCF/β-catenin complex"],"partners":["CTNNB1","SRC","FDXR","HSPD1","HSPE1","CHEK1","NIT1"],"other_free_text":[]},"mechanistic_narrative":"FHIT is a tumor suppressor diadenosine polyphosphate hydrolase that maintains genome stability and modulates apoptosis through mechanisms largely independent of its catalytic activity but dependent on substrate binding and the Src-phosphorylated residue Y114 [PMID:9391102, PMID:15007172, PMID:16407838]. FHIT preserves replication fork integrity by regulating Thymidine kinase 1 expression and nucleotide pool balance; its loss causes replication stress-induced DNA double-strand breaks that serve as substrates for APOBEC3B mutagenesis, initiating a genome-wide mutator phenotype [PMID:23209436, PMID:25401976]. FHIT also partially localizes to mitochondria, where it interacts with Hsp60/Hsp10 and ferredoxin reductase to enhance mitochondrial calcium uptake and ROS-mediated apoptosis, and it directly binds β-catenin at Wnt target gene promoters to repress transcription of cyclin D1 and survivin [PMID:19622739, PMID:19004824, PMID:18077326]. Additionally, FHIT suppresses epithelial-mesenchymal transition through upregulation of miR-30c and modulates the Chk1-dependent DNA damage checkpoint [PMID:25340791, PMID:23102829]."},"prefetch_data":{"uniprot":{"accession":"P49789","full_name":"Bis(5'-adenosyl)-triphosphatase","aliases":["AP3A hydrolase","AP3Aase","Adenosine 5'-monophosphoramidase FHIT","Adenylylsulfatase","Adenylylsulfate-ammonia adenylyltransferase","Diadenosine 5',5'''-P1,P3-triphosphate hydrolase","Dinucleosidetriphosphatase","Fragile histidine triad protein"],"length_aa":147,"mass_kda":16.9,"function":"Possesses dinucleoside triphosphate hydrolase activity (PubMed:12574506, PubMed:15182206, PubMed:8794732, PubMed:9323207, PubMed:9543008, PubMed:9576908). Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP (PubMed:12574506, PubMed:15182206, PubMed:8794732, PubMed:9323207, PubMed:9543008, PubMed:9576908). Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activity with ATP (PubMed:8794732). Exhibits adenylylsulfatase activity, hydrolyzing adenosine 5'-phosphosulfate to yield AMP and sulfate (PubMed:18694747). Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2 (PubMed:18694747). Exhibits adenylylsulfate-ammonia adenylyltransferase, catalyzing the ammonolysis of adenosine 5'-phosphosulfate resulting in the formation of adenosine 5'-phosphoramidate (PubMed:26181368). Also catalyzes the ammonolysis of adenosine 5-phosphorofluoridate and diadenosine triphosphate (PubMed:26181368). Modulates transcriptional activation by CTNNB1 and thereby contributes to regulate the expression of genes essential for cell proliferation and survival, such as CCND1 and BIRC5 (PubMed:18077326). Plays a role in the induction of apoptosis via SRC and AKT1 signaling pathways (PubMed:16407838). Inhibits MDM2-mediated proteasomal degradation of p53/TP53 and thereby plays a role in p53/TP53-mediated apoptosis (PubMed:15313915). Induction of apoptosis depends on the ability of FHIT to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or related compounds, but does not require its catalytic activity, it may in part come from the mitochondrial form, which sensitizes the low-affinity Ca(2+) transporters, enhancing mitochondrial calcium uptake (PubMed:12574506, PubMed:19622739). Functions as a tumor suppressor (By similarity)","subcellular_location":"Cytoplasm; Mitochondrion; Nucleus","url":"https://www.uniprot.org/uniprotkb/P49789/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FHIT","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FHIT","total_profiled":1310},"omim":[{"mim_id":"616769","title":"NITRILASE FAMILY MEMBER 2; NIT2","url":"https://www.omim.org/entry/616769"},{"mim_id":"613984","title":"FANCD2 GENE; FANCD2","url":"https://www.omim.org/entry/613984"},{"mim_id":"609998","title":"HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 3; HINT3","url":"https://www.omim.org/entry/609998"},{"mim_id":"609997","title":"HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2; HINT2","url":"https://www.omim.org/entry/609997"},{"mim_id":"606350","title":"APRATAXIN; APTX","url":"https://www.omim.org/entry/606350"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli fibrillar center","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"choroid plexus","ntpm":607.4}],"url":"https://www.proteinatlas.org/search/FHIT"},"hgnc":{"alias_symbol":["FRA3B","AP3Aase"],"prev_symbol":[]},"alphafold":{"accession":"P49789","domains":[{"cath_id":"3.30.428.10","chopping":"2-143","consensus_level":"high","plddt":95.6933,"start":2,"end":143}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49789","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49789-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49789-F1-predicted_aligned_error_v6.png","plddt_mean":95.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FHIT","jax_strain_url":"https://www.jax.org/strain/search?query=FHIT"},"sequence":{"accession":"P49789","fasta_url":"https://rest.uniprot.org/uniprotkb/P49789.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49789/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49789"}},"corpus_meta":[{"pmid":"8620533","id":"PMC_8620533","title":"The FHIT gene 3p14.2 is abnormal in lung cancer.","date":"1996","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8620533","citation_count":545,"is_preprint":false},{"pmid":"9391102","id":"PMC_9391102","title":"Replacement of Fhit in cancer cells suppresses tumorigenicity.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9391102","citation_count":343,"is_preprint":false},{"pmid":"21258320","id":"PMC_21258320","title":"Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21258320","citation_count":335,"is_preprint":false},{"pmid":"8764101","id":"PMC_8764101","title":"The FHIT gene at 3p14.2 is abnormal in breast carcinomas.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8764101","citation_count":235,"is_preprint":false},{"pmid":"8824874","id":"PMC_8824874","title":"FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites.","date":"1996","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8824874","citation_count":224,"is_preprint":false},{"pmid":"9499431","id":"PMC_9499431","title":"Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9499431","citation_count":201,"is_preprint":false},{"pmid":"10758156","id":"PMC_10758156","title":"Muir-Torre-like syndrome in Fhit-deficient mice.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10758156","citation_count":181,"is_preprint":false},{"pmid":"9928473","id":"PMC_9928473","title":"The role of the FHIT/FRA3B locus in cancer.","date":"1998","source":"Annual review of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9928473","citation_count":169,"is_preprint":false},{"pmid":"15674328","id":"PMC_15674328","title":"Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15674328","citation_count":168,"is_preprint":false},{"pmid":"11248081","id":"PMC_11248081","title":"FHIT gene therapy prevents tumor development in Fhit-deficient mice.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11248081","citation_count":142,"is_preprint":false},{"pmid":"9063739","id":"PMC_9063739","title":"Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9063739","citation_count":135,"is_preprint":false},{"pmid":"9689122","id":"PMC_9689122","title":"The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9689122","citation_count":128,"is_preprint":false},{"pmid":"10728669","id":"PMC_10728669","title":"Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10728669","citation_count":121,"is_preprint":false},{"pmid":"15073846","id":"PMC_15073846","title":"The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.","date":"2004","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15073846","citation_count":121,"is_preprint":false},{"pmid":"9405656","id":"PMC_9405656","title":"Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9405656","citation_count":117,"is_preprint":false},{"pmid":"10377436","id":"PMC_10377436","title":"Cancer-specific chromosome alterations in the constitutive fragile region FRA3B.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10377436","citation_count":114,"is_preprint":false},{"pmid":"12473516","id":"PMC_12473516","title":"FHIT: from gene discovery to cancer treatment and prevention.","date":"2002","source":"The Lancet. Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12473516","citation_count":111,"is_preprint":false},{"pmid":"12771912","id":"PMC_12771912","title":"Cancer and the FRA3B/FHIT fragile locus: it's a HIT.","date":"2003","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12771912","citation_count":103,"is_preprint":false},{"pmid":"18162546","id":"PMC_18162546","title":"Replication stress induces tumor-like microdeletions in FHIT/FRA3B.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18162546","citation_count":97,"is_preprint":false},{"pmid":"25283145","id":"PMC_25283145","title":"The FHIT gene product: tumor suppressor and genome \"caretaker\".","date":"2014","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/25283145","citation_count":83,"is_preprint":false},{"pmid":"23209436","id":"PMC_23209436","title":"Initiation of genome instability and preneoplastic processes through loss of Fhit expression.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23209436","citation_count":80,"is_preprint":false},{"pmid":"9949202","id":"PMC_9949202","title":"Allele-specific late replication and fragility of the most active common fragile site, FRA3B.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9949202","citation_count":80,"is_preprint":false},{"pmid":"8653678","id":"PMC_8653678","title":"Aberrant FHIT transcripts in Merkel cell carcinoma.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8653678","citation_count":79,"is_preprint":false},{"pmid":"9559339","id":"PMC_9559339","title":"An FHIT tumor suppressor gene?","date":"1998","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9559339","citation_count":72,"is_preprint":false},{"pmid":"8813121","id":"PMC_8813121","title":"Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8813121","citation_count":70,"is_preprint":false},{"pmid":"16225988","id":"PMC_16225988","title":"Roles of FHIT and WWOX fragile genes in cancer.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/16225988","citation_count":69,"is_preprint":false},{"pmid":"18077326","id":"PMC_18077326","title":"The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18077326","citation_count":69,"is_preprint":false},{"pmid":"9671749","id":"PMC_9671749","title":"Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9671749","citation_count":64,"is_preprint":false},{"pmid":"10666370","id":"PMC_10666370","title":"Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.","date":"2000","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10666370","citation_count":62,"is_preprint":false},{"pmid":"10096564","id":"PMC_10096564","title":"The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers.","date":"1999","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10096564","citation_count":62,"is_preprint":false},{"pmid":"9699673","id":"PMC_9699673","title":"The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9699673","citation_count":62,"is_preprint":false},{"pmid":"9770345","id":"PMC_9770345","title":"Characterization of PKCI and comparative studies with FHIT, related members of the HIT protein family.","date":"1998","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9770345","citation_count":62,"is_preprint":false},{"pmid":"15007172","id":"PMC_15007172","title":"Fhit is a physiological target of the protein kinase Src.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15007172","citation_count":61,"is_preprint":false},{"pmid":"25340791","id":"PMC_25340791","title":"FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25340791","citation_count":61,"is_preprint":false},{"pmid":"10717620","id":"PMC_10717620","title":"The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.","date":"2000","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10717620","citation_count":60,"is_preprint":false},{"pmid":"16407838","id":"PMC_16407838","title":"Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16407838","citation_count":59,"is_preprint":false},{"pmid":"10618602","id":"PMC_10618602","title":"Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.","date":"2000","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10618602","citation_count":58,"is_preprint":false},{"pmid":"19622739","id":"PMC_19622739","title":"Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19622739","citation_count":58,"is_preprint":false},{"pmid":"25720522","id":"PMC_25720522","title":"Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.","date":"2015","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25720522","citation_count":55,"is_preprint":false},{"pmid":"12007194","id":"PMC_12007194","title":"Direct correlation between FRA3B expression and cigarette smoking.","date":"2002","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12007194","citation_count":54,"is_preprint":false},{"pmid":"10537308","id":"PMC_10537308","title":"Abnormal Fhit expression in malignant and premalignant lesions of the cervix.","date":"1999","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10537308","citation_count":54,"is_preprint":false},{"pmid":"12483524","id":"PMC_12483524","title":"Evidence that instability within the FRA3B region extends four megabases.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12483524","citation_count":54,"is_preprint":false},{"pmid":"11731438","id":"PMC_11731438","title":"Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11731438","citation_count":53,"is_preprint":false},{"pmid":"15026336","id":"PMC_15026336","title":"Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15026336","citation_count":51,"is_preprint":false},{"pmid":"15494723","id":"PMC_15494723","title":"Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.","date":"2004","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15494723","citation_count":50,"is_preprint":false},{"pmid":"10999736","id":"PMC_10999736","title":"Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.","date":"2000","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/10999736","citation_count":50,"is_preprint":false},{"pmid":"11916557","id":"PMC_11916557","title":"High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.","date":"2002","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/11916557","citation_count":49,"is_preprint":false},{"pmid":"24556720","id":"PMC_24556720","title":"Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24556720","citation_count":49,"is_preprint":false},{"pmid":"15389587","id":"PMC_15389587","title":"Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway.","date":"2005","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15389587","citation_count":48,"is_preprint":false},{"pmid":"10363992","id":"PMC_10363992","title":"Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.","date":"1999","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10363992","citation_count":47,"is_preprint":false},{"pmid":"14630947","id":"PMC_14630947","title":"Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14630947","citation_count":47,"is_preprint":false},{"pmid":"9169152","id":"PMC_9169152","title":"Aphidicolin-induced FRA3B breakpoints cluster in two distinct regions.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9169152","citation_count":47,"is_preprint":false},{"pmid":"3125959","id":"PMC_3125959","title":"Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytes.","date":"1988","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/3125959","citation_count":44,"is_preprint":false},{"pmid":"10850413","id":"PMC_10850413","title":"Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10850413","citation_count":43,"is_preprint":false},{"pmid":"10706123","id":"PMC_10706123","title":"Alterations of the FHIT gene in human hepatocellular carcinoma.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10706123","citation_count":42,"is_preprint":false},{"pmid":"9233782","id":"PMC_9233782","title":"FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9233782","citation_count":41,"is_preprint":false},{"pmid":"23494221","id":"PMC_23494221","title":"Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.","date":"2013","source":"International journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23494221","citation_count":40,"is_preprint":false},{"pmid":"17457056","id":"PMC_17457056","title":"A Fhit-ing role in the DNA damage checkpoint response.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17457056","citation_count":39,"is_preprint":false},{"pmid":"32059763","id":"PMC_32059763","title":"RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers.","date":"2020","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32059763","citation_count":39,"is_preprint":false},{"pmid":"10732756","id":"PMC_10732756","title":"Abnormalities of the FHIT gene in human oral carcinogenesis.","date":"2000","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10732756","citation_count":38,"is_preprint":false},{"pmid":"17145874","id":"PMC_17145874","title":"Fhit modulates the DNA damage checkpoint response.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17145874","citation_count":36,"is_preprint":false},{"pmid":"30107138","id":"PMC_30107138","title":"FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.","date":"2019","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30107138","citation_count":35,"is_preprint":false},{"pmid":"18221322","id":"PMC_18221322","title":"Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst.","date":"2008","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18221322","citation_count":35,"is_preprint":false},{"pmid":"11857493","id":"PMC_11857493","title":"Multiple molecular alterations of FHIT in betel-associated oral carcinoma.","date":"2002","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11857493","citation_count":35,"is_preprint":false},{"pmid":"23601052","id":"PMC_23601052","title":"Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D.","date":"2013","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23601052","citation_count":35,"is_preprint":false},{"pmid":"19486340","id":"PMC_19486340","title":"Fragile gene product, Fhit, in oxidative and replicative stress responses.","date":"2009","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/19486340","citation_count":34,"is_preprint":false},{"pmid":"19815620","id":"PMC_19815620","title":"Impaired replication dynamics at the FRA3B common fragile site.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19815620","citation_count":34,"is_preprint":false},{"pmid":"12432269","id":"PMC_12432269","title":"FHIT as tumor suppressor: mechanisms and therapeutic opportunities.","date":"2002","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/12432269","citation_count":34,"is_preprint":false},{"pmid":"9482109","id":"PMC_9482109","title":"Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9482109","citation_count":32,"is_preprint":false},{"pmid":"9403704","id":"PMC_9403704","title":"The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers.","date":"1997","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9403704","citation_count":31,"is_preprint":false},{"pmid":"22451343","id":"PMC_22451343","title":"The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.","date":"2012","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22451343","citation_count":31,"is_preprint":false},{"pmid":"9178887","id":"PMC_9178887","title":"Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9178887","citation_count":29,"is_preprint":false},{"pmid":"15569992","id":"PMC_15569992","title":"Inactivation of the FHIT gene favors bladder cancer development.","date":"2004","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/15569992","citation_count":28,"is_preprint":false},{"pmid":"12353263","id":"PMC_12353263","title":"Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.","date":"2002","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12353263","citation_count":28,"is_preprint":false},{"pmid":"9537583","id":"PMC_9537583","title":"Analysis of FHIT transcripts in cervical and endometrial cancers.","date":"1998","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9537583","citation_count":28,"is_preprint":false},{"pmid":"24244712","id":"PMC_24244712","title":"Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24244712","citation_count":27,"is_preprint":false},{"pmid":"16061637","id":"PMC_16061637","title":"Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16061637","citation_count":27,"is_preprint":false},{"pmid":"25422218","id":"PMC_25422218","title":"Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization.","date":"2014","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/25422218","citation_count":26,"is_preprint":false},{"pmid":"19004824","id":"PMC_19004824","title":"Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19004824","citation_count":26,"is_preprint":false},{"pmid":"10448301","id":"PMC_10448301","title":"FHIT gene abnormalities in both benign and malignant thyroid tumours.","date":"1999","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/10448301","citation_count":25,"is_preprint":false},{"pmid":"18378390","id":"PMC_18378390","title":"Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas.","date":"2008","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/18378390","citation_count":25,"is_preprint":false},{"pmid":"25401976","id":"PMC_25401976","title":"FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25401976","citation_count":24,"is_preprint":false},{"pmid":"11425271","id":"PMC_11425271","title":"Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.","date":"2001","source":"Cancer detection and prevention","url":"https://pubmed.ncbi.nlm.nih.gov/11425271","citation_count":24,"is_preprint":false},{"pmid":"10027001","id":"PMC_10027001","title":"The role of deletions at the FRA3B/FHIT locus in carcinogenesis.","date":"1998","source":"Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10027001","citation_count":23,"is_preprint":false},{"pmid":"29282095","id":"PMC_29282095","title":"Impact of FHIT loss on the translation of cancer-associated mRNAs.","date":"2017","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29282095","citation_count":23,"is_preprint":false},{"pmid":"10652418","id":"PMC_10652418","title":"fhit Alterations in endometrial carcinoma and hyperplasia.","date":"2000","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10652418","citation_count":23,"is_preprint":false},{"pmid":"15007387","id":"PMC_15007387","title":"CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15007387","citation_count":23,"is_preprint":false},{"pmid":"19479888","id":"PMC_19479888","title":"Nit1 and Fhit tumor suppressor activities are additive.","date":"2009","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19479888","citation_count":21,"is_preprint":false},{"pmid":"26171037","id":"PMC_26171037","title":"Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development.","date":"2015","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/26171037","citation_count":20,"is_preprint":false},{"pmid":"10812172","id":"PMC_10812172","title":"Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer.","date":"2000","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10812172","citation_count":20,"is_preprint":false},{"pmid":"22425911","id":"PMC_22425911","title":"Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.","date":"2012","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22425911","citation_count":20,"is_preprint":false},{"pmid":"18091387","id":"PMC_18091387","title":"Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.","date":"2007","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/18091387","citation_count":19,"is_preprint":false},{"pmid":"1427857","id":"PMC_1427857","title":"Detailed mapping around the breakpoint of (3;8) translocation in familial renal cell carcinoma and FRA3B.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1427857","citation_count":18,"is_preprint":false},{"pmid":"23102829","id":"PMC_23102829","title":"Characterization of the role of Fhit in suppression of DNA damage.","date":"2012","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/23102829","citation_count":18,"is_preprint":false},{"pmid":"37029227","id":"PMC_37029227","title":"Acetylcholine promotes chronic stress-induced lung adenocarcinoma progression via α5-nAChR/FHIT pathway.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/37029227","citation_count":17,"is_preprint":false},{"pmid":"18299890","id":"PMC_18299890","title":"Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas.","date":"2008","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18299890","citation_count":17,"is_preprint":false},{"pmid":"11768238","id":"PMC_11768238","title":"Distribution of Fhit protein in rat tissues and its intracellular localization.","date":"2001","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11768238","citation_count":16,"is_preprint":false},{"pmid":"10571505","id":"PMC_10571505","title":"Loss or reduction of Fhit expression in renal neoplasias: correlation with histogenic class.","date":"1999","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10571505","citation_count":16,"is_preprint":false},{"pmid":"21711110","id":"PMC_21711110","title":"microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression.","date":"2011","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/21711110","citation_count":16,"is_preprint":false},{"pmid":"12697969","id":"PMC_12697969","title":"Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus.","date":"2003","source":"Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12697969","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48134,"output_tokens":4306,"usd":0.104496},"stage2":{"model":"claude-opus-4-6","input_tokens":7811,"output_tokens":3446,"usd":0.187807},"total_usd":0.292303,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Fhit protein hydrolyzes dinucleotide 5',5'''-P1,P3-triphosphate (ApppA) in vitro; mutation of the central histidine abolishes hydrolase activity. Tumor suppression activity does not require the hydrolase activity, as hydrolase-dead Fhit mutants still suppress tumorigenicity in nude mice.\",\n      \"method\": \"In vitro enzymatic assay, active-site mutagenesis, nude mouse tumorigenicity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of enzymatic activity with mutagenesis, validated by in vivo functional assay\",\n      \"pmids\": [\"9391102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Drosophila and C. elegans encode Fhit as a fusion protein with a nitrilase domain (NitFhit); the Drosophila fusion protein retains diadenosine triphosphate (ApppA) hydrolase activity. In mammals, FHIT and NIT1 are encoded by separate genes, suggesting they collaborate in a common biochemical pathway.\",\n      \"method\": \"Cloning, enzymatic activity assay of fusion protein, expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay of ortholog fusion protein with functional evolutionary inference\",\n      \"pmids\": [\"9671749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Fhit is phosphorylated on tyrosine 114 (Y114) by the Src protein kinase both in vitro and in vivo, identifying Fhit as a physiological Src substrate.\",\n      \"method\": \"In vitro kinase assay, in vivo phosphorylation studies\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and in vivo phosphorylation demonstrated with site-specific identification\",\n      \"pmids\": [\"15007172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Fhit Y114 residue is essential for caspase-dependent apoptosis induction in lung cancer cells; wild-type but not Y114 mutant Fhit inhibits Akt activity and reduces survivin expression, placing Fhit upstream of the PI3K-Akt-survivin pathway.\",\n      \"method\": \"Adenoviral infection with wild-type and Y114 mutant FHIT, expression profiling, Akt activity assay, apoptosis assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-specific mutagenesis with multiple orthogonal functional readouts (apoptosis, Akt activity, survivin expression)\",\n      \"pmids\": [\"16407838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Fhit directly binds to the C-terminal domain of β-catenin, recruits to Wnt target gene promoters (cyclin D1, axin2, MMP-14, survivin) as part of the LEF1/TCF/β-catenin complex, and represses transcription of these targets. Enzymatic activity is not required for this function.\",\n      \"method\": \"Co-IP, ChIP, knockdown experiments, soft-agar assay, enzymatic dead mutant analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assays, ChIP, and functional mutagenesis with multiple orthogonal methods\",\n      \"pmids\": [\"18077326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Fhit modulates the mid-S DNA damage checkpoint by regulating expression of checkpoint proteins Hus1 and Chk1; mutation of Fhit Y114 abolishes this checkpoint modulation, and re-expression induces apoptosis in cancer cells but not normal cells.\",\n      \"method\": \"Exogenous Fhit expression in cells, Western blot for checkpoint proteins, apoptosis assay, Y114 mutant analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined pathway placement with mutagenesis, single lab\",\n      \"pmids\": [\"17145874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Fhit localizes partially to mitochondria and enhances mitochondrial calcium uptake, sensitizing cells to apoptosis. A chimeric fully mitochondrial Fhit retains Ca2+ signaling and proapoptotic properties but loses effects on cell cycle.\",\n      \"method\": \"Subcellular fractionation, live imaging of Ca2+ signaling in intact and permeabilized cells, chimeric protein expression, apoptosis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct localization experiments with functional consequence established by chimeric protein approach and Ca2+ measurements\",\n      \"pmids\": [\"19622739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Fhit interacts with Hsp60/Hsp10 chaperone machinery and ferredoxin reductase (Fdxr); substrate-binding and Y114 phosphorylation are required for these interactions and for mitochondrial localization. Loss of these interactions reduces Fhit tumor suppressor activity and impairs oxidative stress-induced apoptosis.\",\n      \"method\": \"Chemical cross-linking, immunoprecipitation, subcellular fractionation, mutant expression, flow cytometry, ROS measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution of protein complex with mutagenesis and multiple functional readouts\",\n      \"pmids\": [\"19004824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Fhit binds and stabilizes ferredoxin reductase (Fdxr) in mitochondria; when Fdxr is overexpressed it produces reactive oxygen species (ROS) that induce apoptosis. Fhit-positive cancer cells produce higher ROS upon H2O2 exposure than Fhit-negative cells.\",\n      \"method\": \"Immunoprecipitation, ROS measurement, apoptosis assay, overexpression experiments\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and functional assay, single lab\",\n      \"pmids\": [\"19486340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Fhit depletion causes replication stress-induced DNA double-strand breaks and defective replication fork progression (fork stalling and collapse). The mechanism involves regulation of Thymidine kinase 1 (TK1) expression and thymidine triphosphate pool levels; restoring nucleotide balance rescues replication defects and suppresses DNA breakage in Fhit-deficient cells.\",\n      \"method\": \"DNA combing, DNA damage markers, TK1 expression analysis, thymidine supplementation rescue, Fhit knockout mouse tissue analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including direct replication fork analysis, rescue experiments, and in vivo validation\",\n      \"pmids\": [\"23209436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Silencing Fhit gene expression in MHC-I-positive tumor cells causes transcriptional down-regulation of antigen-processing machinery (APM) components and MHC-I heavy chains, reducing MHC-I surface expression. Transfection of Fhit into MHC-I-negative tumor cells restores MHC-I surface expression.\",\n      \"method\": \"siRNA knockdown, FHIT transfection, flow cytometry, RT-PCR\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional gain/loss of function experiments with defined cellular phenotype\",\n      \"pmids\": [\"22451343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FHIT suppresses EMT and metastasis in lung cancer through upregulation of miR-30c, which directly targets metastasis genes MTDH, HMGA2, VIM, and FN1.\",\n      \"method\": \"In vivo metastasis assay, in vitro migration/invasion assay, miRNA target validation, gain/loss of function experiments\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro assays with defined molecular targets, single lab\",\n      \"pmids\": [\"25340791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nit1 and Fhit tumor suppressor activities are additive in vivo; double Fhit(-/-)Nit1(-/-) knockout mice develop more tumors than Fhit(-/-) mice alone, suggesting they act in distinct pathways in mammals. Both Nit1 and Fhit localize to cytoplasm and mitochondria but not nuclei.\",\n      \"method\": \"Double knockout mouse tumor susceptibility assay, subcellular fractionation/localization, cell stress assays\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via double-knockout mouse model with defined phenotypic readout\",\n      \"pmids\": [\"19479888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Fhit function in suppressing DNA damage requires a functional HIT domain and the Y114 residue, is independent of Atr or Atm kinases, but is dependent on Chk1 kinase activity, suggesting Fhit and Chk1 cooperate to prevent replication stress-induced DNA damage.\",\n      \"method\": \"Mutant expression studies, kinase inhibitor experiments, DNA damage assays in Fhit-deficient cells\",\n      \"journal\": \"Advances in biological regulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis and epistasis by kinase inhibition, single lab\",\n      \"pmids\": [\"23102829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Fhit loss-induced DNA damage (via reduced TK1 and replication stress) creates optimal substrates for APOBEC3B-mediated mutagenesis; FHIT-low/APOBEC3B-high lung adenocarcinomas display significantly increased APOBEC signature mutations. Thymidine supplementation (rescuing nucleotide balance) decreases APOBEC-induced TP53 mutations in FHIT-low cells.\",\n      \"method\": \"TCGA data analysis, in vitro FHIT silencing, TP53 mutation analysis, thymidine rescue experiments\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — mechanistic link established by rescue experiment in vitro, supported by TCGA data\",\n      \"pmids\": [\"25401976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FHIT functions as a BMPR2 modifier; reduced FHIT expression is associated with endothelial and smooth muscle cell dysfunction in pulmonary arterial hypertension. Fhit-/- mice develop exaggerated hypoxic pulmonary hypertension. Enzastaurin upregulates FHIT expression and reverses experimental pulmonary hypertension.\",\n      \"method\": \"siRNA high-throughput screen, Fhit knockout mouse model, pharmacological rescue (enzastaurin), in vitro cell dysfunction assays\",\n      \"journal\": \"American journal of respiratory and critical care medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knockout mouse phenotype with pharmacological rescue, mechanistic link to BMPR2 pathway defined\",\n      \"pmids\": [\"30107138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Fhit protein is localized to the cytosolic compartment in renal tubular epithelium, as determined by immunofluorescence and biochemical fractionation.\",\n      \"method\": \"Immunofluorescence, biochemical subcellular fractionation\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by two independent methods\",\n      \"pmids\": [\"9403704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Fhit protein is localized to the nucleus and plasma membrane in rat tissues, as determined by subcellular fractionation of multiple tissues.\",\n      \"method\": \"Biochemical fractionation, immunoblot analysis of subcellular fractions\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single method, single lab; conflicts with other localization data\",\n      \"pmids\": [\"11768238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Fhit expression impacts translation of hundreds of cancer-associated mRNAs, including changes in 5'-UTR ribosome occupancy; this is consistent with Fhit's enzymatic ability to degrade m7GpppN caps generated during 3'-5' mRNA decay, potentially affecting translational regulation.\",\n      \"method\": \"Ribosome profiling (ribosome occupancy assay) in Fhit-positive vs. Fhit-negative cells\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ribosome profiling with mechanistic hypothesis grounded in Fhit enzymatic activity\",\n      \"pmids\": [\"29282095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Acetylcholine promotes lung adenocarcinoma cell migration and invasion via the α5-nAChR/DNMT1/FHIT axis; α5-nAChR activation increases DNMT1 expression, which methylates and silences FHIT, promoting EMT.\",\n      \"method\": \"In vivo chronic stress mouse model, in vitro cell migration/invasion assays, DNMT1 overexpression/silencing, FHIT methylation analysis\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro mechanistic pathway defined with multiple components\",\n      \"pmids\": [\"37029227\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Fhit is a diadenosine polyphosphate hydrolase whose tumor suppressor functions are largely independent of its catalytic activity but require substrate binding and the tyrosine-114 residue; Fhit acts through multiple mechanisms including: direct binding to β-catenin to repress Wnt target gene transcription, partial localization to mitochondria where it interacts with Hsp60/Hsp10 and ferredoxin reductase to modulate ROS-induced apoptosis and intramitochondrial calcium uptake, regulation of Thymidine kinase 1 expression to maintain nucleotide pool balance and prevent replication stress-induced DNA breaks, modulation of the Chk1-dependent DNA damage checkpoint, and upregulation of miR-30c to suppress EMT-related genes; Fhit is also phosphorylated by Src kinase at Y114, and its loss initiates a mutator phenotype through genome instability that facilitates oncogenic progression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FHIT is a tumor suppressor diadenosine polyphosphate hydrolase that maintains genome stability and modulates apoptosis through mechanisms largely independent of its catalytic activity but dependent on substrate binding and the Src-phosphorylated residue Y114 [PMID:9391102, PMID:15007172, PMID:16407838]. FHIT preserves replication fork integrity by regulating Thymidine kinase 1 expression and nucleotide pool balance; its loss causes replication stress-induced DNA double-strand breaks that serve as substrates for APOBEC3B mutagenesis, initiating a genome-wide mutator phenotype [PMID:23209436, PMID:25401976]. FHIT also partially localizes to mitochondria, where it interacts with Hsp60/Hsp10 and ferredoxin reductase to enhance mitochondrial calcium uptake and ROS-mediated apoptosis, and it directly binds β-catenin at Wnt target gene promoters to repress transcription of cyclin D1 and survivin [PMID:19622739, PMID:19004824, PMID:18077326]. Additionally, FHIT suppresses epithelial-mesenchymal transition through upregulation of miR-30c and modulates the Chk1-dependent DNA damage checkpoint [PMID:25340791, PMID:23102829].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that FHIT is a diadenosine triphosphate hydrolase whose tumor suppression is catalytically independent resolved the paradox of how a metabolic enzyme could function as a tumor suppressor.\",\n      \"evidence\": \"In vitro enzymatic assay with active-site mutagenesis; hydrolase-dead mutants still suppressed tumorigenicity in nude mice\",\n      \"pmids\": [\"9391102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The substrate-binding vs. catalytic distinction was not yet mapped to specific residues beyond the catalytic histidine\", \"The downstream effector pathway for tumor suppression was unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Discovery that Drosophila and C. elegans encode FHIT fused with a nitrilase domain (NitFhit) established evolutionary conservation and suggested functional collaboration with NIT1 in mammals.\",\n      \"evidence\": \"Cloning and enzymatic assay of Drosophila NitFhit fusion protein\",\n      \"pmids\": [\"9671749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The shared biochemical pathway between FHIT and NIT1 in mammals was not identified\", \"Whether the fusion architecture reflects obligate functional coupling was unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of Y114 as a Src phosphorylation site provided the first post-translational regulatory mechanism for FHIT and a critical residue for subsequent functional dissection.\",\n      \"evidence\": \"In vitro kinase assay and in vivo phosphorylation studies\",\n      \"pmids\": [\"15007172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Y114 phosphorylation on tumor suppression was not yet tested\", \"Whether Src-mediated phosphorylation activates or inhibits FHIT was unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstration that Y114 is required for caspase-dependent apoptosis and Akt/survivin pathway inhibition linked Src phosphorylation to a defined tumor-suppressive signaling axis, and that FHIT modulates the Hus1/Chk1 DNA damage checkpoint.\",\n      \"evidence\": \"Y114 mutant vs. wild-type adenoviral expression in lung cancer cells with apoptosis, Akt activity, and checkpoint protein readouts\",\n      \"pmids\": [\"16407838\", \"17145874\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Akt inhibition is direct or indirect was not resolved\", \"Relationship between checkpoint modulation and apoptosis induction was unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that FHIT directly binds β-catenin and represses Wnt target gene transcription independently of catalytic activity revealed a nuclear transcriptional repressor function distinct from its metabolic role.\",\n      \"evidence\": \"Co-IP, ChIP at Wnt target promoters, knockdown, enzymatic-dead mutant analysis\",\n      \"pmids\": [\"18077326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of transcriptional repression (co-repressor recruitment, chromatin remodeling) was not defined\", \"Whether FHIT enters the nucleus or acts at the cytoplasmic level on β-catenin was not fully clarified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of Hsp60/Hsp10 and ferredoxin reductase as mitochondrial FHIT-interacting partners, requiring substrate-binding and Y114, established a mitochondrial axis for FHIT's proapoptotic function through ROS generation.\",\n      \"evidence\": \"Chemical cross-linking, immunoprecipitation, subcellular fractionation, ROS measurement with mutant panel\",\n      \"pmids\": [\"19004824\", \"19486340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How FHIT is imported into mitochondria without a canonical transit peptide was unknown\", \"Whether Fdxr stabilization is sufficient for ROS-mediated apoptosis independently of other FHIT functions was unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that mitochondrial FHIT enhances calcium uptake and sensitizes cells to apoptosis — while a fully mitochondrial chimera loses cell-cycle effects — separated FHIT's mitochondrial proapoptotic function from its cytoplasmic/nuclear roles.\",\n      \"evidence\": \"Live Ca2+ imaging in intact and permeabilized cells, chimeric mitochondrial-targeted FHIT\",\n      \"pmids\": [\"19622739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The calcium channel or transporter modulated by FHIT was not identified\", \"Quantitative contribution of mitochondrial vs. non-mitochondrial FHIT to tumor suppression in vivo was undefined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Double-knockout mouse studies showing additive tumor susceptibility of Fhit and Nit1 loss established that these evolutionarily linked genes act through distinct tumor-suppressive pathways in mammals.\",\n      \"evidence\": \"Fhit−/−Nit1−/− double-knockout mouse tumorigenesis assay with subcellular localization\",\n      \"pmids\": [\"19479888\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The Nit1-specific pathway was not defined\", \"Whether cytoplasmic vs. mitochondrial co-localization mediates any residual functional overlap was not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that FHIT loss causes replication fork collapse through TK1 downregulation and nucleotide imbalance provided the first genome-instability mechanism for FHIT tumor suppression, explaining how early FHIT loss drives a mutator phenotype.\",\n      \"evidence\": \"DNA combing, DNA damage markers, TK1 expression, thymidine supplementation rescue, Fhit-knockout mouse validation\",\n      \"pmids\": [\"23209436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How FHIT regulates TK1 transcription was not established\", \"Whether nucleotide imbalance fully accounts for all FHIT-dependent DNA damage was unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Epistasis experiments placed FHIT's DNA-damage suppression as dependent on Chk1 but independent of ATR/ATM, refining its position in the replication stress response.\",\n      \"evidence\": \"Kinase inhibitor experiments with FHIT mutants and DNA damage assays\",\n      \"pmids\": [\"23102829\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical or signaling link between FHIT and Chk1 was not shown\", \"How FHIT bypasses ATR-dependent Chk1 activation was unexplained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of miR-30c as a FHIT-induced microRNA that suppresses EMT genes (MTDH, HMGA2, VIM, FN1) extended FHIT's tumor-suppressive reach to metastasis and epithelial-mesenchymal transition control.\",\n      \"evidence\": \"In vivo metastasis assay, miRNA target validation, gain/loss-of-function in lung cancer cells\",\n      \"pmids\": [\"25340791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which FHIT upregulates miR-30c was not defined\", \"Whether miR-30c mediates FHIT effects in non-lung tissues was untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linking FHIT loss-induced replication stress to APOBEC3B mutagenesis explained how early FHIT silencing amplifies the somatic mutation burden driving cancer progression.\",\n      \"evidence\": \"TCGA analysis of FHIT-low/APOBEC3B-high tumors, in vitro FHIT silencing with thymidine rescue reducing APOBEC-induced TP53 mutations\",\n      \"pmids\": [\"25401976\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether APOBEC3B access to ssDNA at stalled forks is the sole mechanism was not proven\", \"In vivo validation in mouse models was lacking\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Ribosome profiling revealed that FHIT expression reshapes translation of hundreds of cancer-associated mRNAs, consistent with its ability to degrade m7GpppN cap dinucleotides from mRNA decay intermediates.\",\n      \"evidence\": \"Genome-wide ribosome occupancy profiling in FHIT-positive vs. FHIT-negative cells\",\n      \"pmids\": [\"29282095\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct evidence that cap-dinucleotide hydrolysis by FHIT alters specific mRNA translation was not provided\", \"Whether translational changes are primary or secondary to FHIT's other functions was unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that FHIT modifies the BMPR2 pulmonary arterial hypertension phenotype, with Fhit−/− mice developing exaggerated hypoxic pulmonary hypertension reversed by enzastaurin, extended FHIT's physiological roles beyond cancer.\",\n      \"evidence\": \"siRNA screen, Fhit-knockout mouse hypoxia model, pharmacological rescue with enzastaurin\",\n      \"pmids\": [\"30107138\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism linking FHIT to BMPR2 signaling was not defined\", \"Whether replication stress or other FHIT pathways mediate the vascular phenotype was unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which FHIT regulates TK1 transcription, how it is imported into mitochondria without a canonical transit peptide, and whether its translational regulatory function via cap-dinucleotide hydrolysis is physiologically significant remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No transcription factor or promoter element identified for FHIT-dependent TK1 regulation\", \"Mitochondrial import mechanism is undefined\", \"Causal link between cap hydrolysis and translational changes is not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 5, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [6, 7, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 5, 15]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 6, 7, 8]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [9, 13, 14]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [9, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 11, 14]}\n    ],\n    \"complexes\": [\n      \"LEF1/TCF/β-catenin complex\"\n    ],\n    \"partners\": [\n      \"CTNNB1\",\n      \"SRC\",\n      \"FDXR\",\n      \"HSPD1\",\n      \"HSPE1\",\n      \"CHEK1\",\n      \"NIT1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}